| Name | Bexmarilimab |
|---|
| Description | Bexmarilimab (FP-1305) is a potent humanized anti-CLEVER-1 IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |